Aller au contenu principal
Accès ouvert déclaré 2019 article

Incidence, Mortality, and Burden of Severe Acute Respiratory Infection in Iran in 2015

1Citations signalées, ce qui n’est pas une note de qualité
5Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : ir. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Severe Acute Respiratory Infection (SARI) is responsible for mortality and hospital admissions in millions of people across the world. The present study, for the first time, aimed at estimating the incidence, mortality, and burden of SARI in Iran in 2015. Methods: Disability Adjusted Life Years (DALYs) was used as an index to estimate the burden of SARI. The SARI-related DALYs was calculated using a method developed by the WHO for assessing the Global Burden of Diseases. DALYs are calculated as the sum of the Years Lost due to Disability (YLDs) and the Years of Life Lost (YLLs) due to premature mortality. The data on the incidence and mortality were obtained from the SARI surveillance system of Iran's Ministry of Health and Medical Education. The average duration until remission or death and the disease disability weight were set at four weeks and 0.373, respectively. Results: In 2015, the incidence of SARI was 21309 and 20885 among males and females, respectively. Moreover, 773 males and 737 females died from this disease (Case fatality rate was about 0.035). Total SARI-related DALYs in males and females was 17264 and 16720, respectively. Furthermore, YLLs was responsible for more than 96% of SARI-related DALYs in 2015. Conclusion: There was no significant difference between males and females in terms of the incidence, mortality, and burden of SARI in 2015. Epidemiological data are required to adopt appropriate policies and responses to prevent and control SARI. The incidence, mortality, fatality, and burden of SARI are significant in Iran. It is necessary to develop appropriate strategies, such as vaccination against major pathogens of the disease at least in high-risk groups, strengthening the disease surveillance system, and attracting the attention of policy makers and health authorities of the country.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

Aucun DOI disponible pour le contrôle Crossref.

Où se fait cette recherche

  • Kurdistan University of Medical Sciences Social Determinants of Health Research Center pays non établi dans la notice
    Université ou école supérieure
  • Urmia University pays non établi dans la notice
    Université ou école supérieure
  • Urmia University of Medical Sciences pays non établi dans la notice
    Université ou école supérieure
  • Iran University of Medical Sciences Health Promotion Research Center pays non établi dans la notice
    Université ou école supérieure
  • Ministry of Health and Medical Education Center for Communicable Disease Control pays non établi dans la notice
    Organisme public
  • School of Health Department of Public Health pays non établi dans la notice
    Université ou école supérieure
  • Faculty of Medicine Department of Pediatrics pays non établi dans la notice
    Université ou école supérieure

Social Determinants of Health Research Center — Kurdistan University of Medical Sciences, Urmia University et Urmia University of Medical Sciences, avec 4 autres affiliations.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Pneumonia and Respiratory InfectionsHealth and Well-being StudiesGlobal Health and Epidemiology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.